NewsRx

Search our medical news database

Information Technology

Verispan's informatics software identifies top 10 drug classes affected by Medicare Part D

Published in Drug Law Weekly, April 11th, 2006

Verispan's Vector One: Payer application has been used to identify the top 10 drug classes impacted by Medicare Part D in January 2006 compared to usage in these classes by those 65 and older in all of 2005. Classes whose utilization appears to be most affected by Part D include many of the most common therapeutic areas.

Top 10 drug classes impacted by Part D total prescriptions (TRxs) filled by Part D participants (all ages) per class in January 2006, compared to usage by 65 and older population in 2005 are as follows: HMG-CoA reductase inhibitor; beta-blockers; ACE inhibitors, alone; calcium blockers; codeine and combinations, non-injected; proton pump inhibitors;...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook